Smoking, eicosanoids and ulcerative colitis
- 1 April 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 42 (4) , 288-289
- https://doi.org/10.1111/j.2042-7158.1990.tb05411.x
Abstract
In this study, which is the first of its kind using normal tissue samples that are very difficult to obtain, we have investigated the hypothesis that smoking protects against ulcerative colitis by altering the colonic mucosal formation of prostaglandins and related substances. Colonic mucosa biopsied from healthy young men produced prostaglandin E, 6-keto-PGF1α (formed from PGI2), leukotriene B4 and leukotriene C4/D4/E4 as determined by radioimmunoassay. With each substance, the median yield was lower in the group of smokers who smoked 3 cigarettes in the 2 h before biopsy, than in the non-smokers. However, with each eicosanoid the statistical probability approached only the 10% level, but the fact that the trend was the same for all eicosanoids somewhat strengthens the possibility of a real difference between the groups.This publication has 6 references indexed in Scilit:
- Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitisGastroenterology, 1986
- Active Smoking Depresses Prostaglandin Synthesis in Human Gastric MucosaAnnals of Internal Medicine, 1986
- Non-smoking: a feature of ulcerative colitis.BMJ, 1982
- Role of Prostaglandins in Ulcerative ColitisGastroenterology, 1978
- ROLE OF PROSTAGLANDINS IN ULCERATIVE-COLITIS - ENHANCED PRODUCTION DURING ACTIVE DISEASE AND INHIBITION BY SULFASALAZINE1978